Nina Niu Sanford, Associate Professor and Chief of Gastrointestinal Radiation Oncology Service, shared a post by American Society for Radiation Oncology(ASTRO) on X, adding:
“SBRT (50Gy/5fx, MR adaptive) in locally recurrent PDAC.
N=46 (7 w prior RT). 1 year LC 73%, median OS 19 mo. Ablative RT = feasible, safe in locally recurrent setting and can confer long term dz control.
Great to see this data published – congrats Hyun Kim and team!”
Quoting ASTRO’s post:
“New in practical RO: Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery.
Other articles featuring Nina Niu Sanford on OncoDaily.